© 2021 BioMarin. All rights reserved.
Read about BioMarin’s latest achondroplasia announcement in Europe
We are committed to the communities we treat beyond the therapies we develop.
Each drug candidate we pursue is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address.